was successfully added to your cart.

Your SEO optimized title page contents

Federal Spending Bill allows for Medical Marijuana

Federal Spending Bill allows for Medical Cannabis

On Tuesday, December 16th, President Obama signed a new spending bill that would keep the federal government operating over the next nine months. This is one of the last acts of Congress that the two bipartisan chambers will pass before Congress returns to session in January with a Republican controlled House and Senate. Among other things the measure rolls back some banking regulations, cuts spending to the EPA, retains spending for the health care system and gives pay raises to soldiers. Nestled within all of these seemingly typical changes is a piece of monumental legislation for the cannabis movement. Section 538 reads, “None of the funds made available in this Act to the Department of Justice may be used, with respect to the States [list states with medical marijuana bills] to prevent such States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana.”

You would think there would have been more of a fuss regarding the issue due to the twenty-year face-off between medical states and the federal government, but instead the measure was coyly snuck into the 1603 page document. Section 538 was supported by both Republicans and Democrats, assumingly so because it was presented as a matter of State’s rights. In reality the approval of the measure has a lot more to do with changing public opinion, the worldwide media attention high-CBD strains have received, and the growing notion that going against medical marijuana would be political PR suicide.

Federal Spending Bill allows for Medical Marijuana

Since President Obama has been in office federal raids of medical cultivators and dispensaries has dropped significantly, yet zealot federal agents have continued raids, especially in California. With this new measure, it is forbidden for federal money to be spent in interference with state medical marijuana laws. It does not warrant an umbrella of protection though as organizations can still be investigated for tax evasion, money laundering, or other federally punishable offenses. Due to the unregulated nature of dispensaries over the last ten years, many have been operating without ever registering with their states and paying the necessary taxes on sales. For example, Washington State has been cracking down on such operations since 2011, but it remains unclear whether or not federal agents would be allowed to bust the organizations that have not filed with their states. Some medical dispensary owners and collectives argue that they are nonprofit businesses that should be tax exempt.

Although section 538 has allowed state’s to set their own ways regarding medical marijuana, section 809 of the spending bill prohibits federal money from being used to “enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance,” which includes marijuana.  This would curtail the implementation of the recreational bill Initiative 71 which passed in Washington D.C. in November. Even though it has over 70% approval rating by voters, this section would mitigate the previous decriminalization efforts and make it illegal to have any amount of cannabis.

Any way you look at it, the new spending bill is a giant step forward for the cannabis movement in granting truly safe access for patients to their medicine.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply